Page last updated: 2024-10-21

1,3-dipropyl-8-cyclopentylxanthine and Lung Diseases

1,3-dipropyl-8-cyclopentylxanthine has been researched along with Lung Diseases in 2 studies

DPCPX : An oxopurine that is 7H-xanthine substituted at positions 1 and 3 by propyl groups and at position 8 by a cyclohexyl group.

Lung Diseases: Pathological processes involving any part of the LUNG.

Research Excerpts

ExcerptRelevanceReference
"Pretreatment with adenosine, A2 agonist, A1 antagonist, and isoproterenol blocked the increase in Kf,c induced by PMA."1.29Adenosine prevents PMA-induced lung injury via an A2 receptor mechanism. ( Adkins, WK; Allison, RC; Barnard, JW; Moore, TM; Prasad, VR; Taylor, AE, 1993)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Adkins, WK1
Barnard, JW1
Moore, TM1
Allison, RC1
Prasad, VR1
Taylor, AE1
Neely, CF1
Jin, J1
Keith, IM1

Other Studies

2 other studies available for 1,3-dipropyl-8-cyclopentylxanthine and Lung Diseases

ArticleYear
Adenosine prevents PMA-induced lung injury via an A2 receptor mechanism.
    Journal of applied physiology (Bethesda, Md. : 1985), 1993, Volume: 74, Issue:3

    Topics: Adenosine; Animals; Blood Pressure; Capillary Permeability; Cyclic AMP; Dogs; Endothelium; Female; I

1993
A1-adenosine receptor antagonists block endotoxin-induced lung injury.
    The American journal of physiology, 1997, Volume: 272, Issue:2 Pt 1

    Topics: Animals; Cats; Endotoxins; Lung; Lung Diseases; Microscopy, Electron; Purinergic P1 Receptor Antagon

1997